Sophia Genetics (FRA:90B) Net Interest Margin (Bank Only) %


FRA:90B Sophia Genetics SA FRA:90B
73 GF Score
Price €4.84
GF Value €4.56
Valuation Fairly Valued
! 6 Warning Signs
View Full Analysis

What is Sophia Genetics Net Interest Margin (Bank Only) %?

Net Interest Margin (Bank Only) % only applies to banks.

FRA:90B
73GF Score
Sophia Genetics SA FRA:90B
Net Interest Margin (Bank Only) % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Sophia Genetics (FRA:90B) Overvalued in 2026?

Based on GuruFocus' analysis, Sophia Genetics stock appears to be overvalued. The current stock price of €4.84 is trading 6.1% above its estimated GF Value™ of €4.56. GuruFocus considers Sophia Genetics to be Fairly Valued.

Key valuation signals for FRA:90B:

  • Net Interest Margin (Bank Only) %:
  • GF Value™: €4.56 vs. price of €4.84 (6.1% above fair value)
  • GF Score™: 73/100 with 6 warning signs

No single metric tells the full story. See the FRA:90B stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Sophia Genetics Business Description

Other Exchanges SOPH:USA90B:Germany
Address La Piece 12, Rolle, CHE, CH-1180
Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.
73GF Score

Get the complete analysis for FRA:90B

Net Interest Margin (Bank Only) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€4.84
Price
€4.56
GF Value